Arizona State Retirement System Has $848,000 Stock Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Arizona State Retirement System reduced its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 1.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,849 shares of the company’s stock after selling 250 shares during the quarter. Arizona State Retirement System’s holdings in Prestige Consumer Healthcare were worth $848,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. BlackRock Inc. raised its holdings in Prestige Consumer Healthcare by 12.4% during the 1st quarter. BlackRock Inc. now owns 9,115,718 shares of the company’s stock worth $482,584,000 after purchasing an additional 1,004,337 shares during the last quarter. Vanguard Group Inc. raised its holdings in Prestige Consumer Healthcare by 0.6% during the 3rd quarter. Vanguard Group Inc. now owns 5,647,622 shares of the company’s stock worth $281,421,000 after purchasing an additional 32,646 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Prestige Consumer Healthcare by 0.4% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,448,246 shares of the company’s stock worth $182,552,000 after purchasing an additional 12,790 shares during the last quarter. Macquarie Group Ltd. raised its holdings in Prestige Consumer Healthcare by 39.6% during the 1st quarter. Macquarie Group Ltd. now owns 2,753,431 shares of the company’s stock worth $172,447,000 after purchasing an additional 781,431 shares during the last quarter. Finally, Ariel Investments LLC raised its holdings in Prestige Consumer Healthcare by 173.8% during the 3rd quarter. Ariel Investments LLC now owns 2,534,786 shares of the company’s stock worth $144,964,000 after purchasing an additional 1,609,044 shares during the last quarter. 99.95% of the stock is owned by institutional investors.

Analysts Set New Price Targets

PBH has been the subject of a number of recent analyst reports. TheStreet raised Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research note on Monday, February 12th. StockNews.com raised Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, February 10th. One research analyst has rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $110.00.

Prestige Consumer Healthcare Price Performance

Shares of PBH opened at $68.03 on Thursday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.92 and a current ratio of 3.09. The stock has a 50 day simple moving average of $70.69 and a 200 day simple moving average of $63.64. Prestige Consumer Healthcare Inc. has a 52-week low of $55.96 and a 52-week high of $75.31. The firm has a market capitalization of $3.38 billion, a PE ratio of -41.48, a P/E/G ratio of 1.85 and a beta of 0.52.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings data on Thursday, February 8th. The company reported $1.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.02. Prestige Consumer Healthcare had a positive return on equity of 14.09% and a negative net margin of 7.11%. The business had revenue of $282.74 million during the quarter, compared to analyst estimates of $280.25 million. During the same period in the previous year, the firm earned $1.04 EPS. Prestige Consumer Healthcare’s quarterly revenue was up 2.6% compared to the same quarter last year. Sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.33 EPS for the current fiscal year.

Insiders Place Their Bets

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 5,336 shares of the company’s stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $69.00, for a total transaction of $368,184.00. Following the completion of the transaction, the senior vice president now owns 15,934 shares of the company’s stock, valued at approximately $1,099,446. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 1.60% of the company’s stock.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.